(Q43660211)

25 November 2017

Dose response to nitric oxide in adult cardiac surgery patients (English)

1 reference

25 November 2017

Solina AR

1

1 reference

25 November 2017

Ginsberg SH

2

1 reference

25 November 2017

Papp D

3

1 reference

25 November 2017

Grubb WR

4

1 reference

25 November 2017

Scholz PM

5

1 reference

25 November 2017

Pantin EJ

6

1 reference

25 November 2017

Cody RP

7

1 reference

25 November 2017

Krause TJ

8

1 reference

25 November 2017

1 June 2001

1 reference

Journal of Clinical Anesthesia

25 November 2017

1 reference

25 November 2017

13

1 reference

25 November 2017

4

1 reference

25 November 2017

281-286

1 reference

Inhaled nitric oxide: therapeutic applications in cardiothoracic surgery

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

Effective control of refractory pulmonary hypertension after cardiac operations

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

Effective control of pulmonary vascular resistance with inhaled nitric oxide after cardiac operation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

Nitric oxide gives maximal response after coronary artery bypass surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

Inhaled nitric oxide in acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

Dose response to inhaled nitric oxide in pediatric patients with pulmonary hypertension and acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

Efficacy of inhaled nitric oxide in children with ARDS

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

Acute effects of inhaled nitric oxide in adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

Randomised trial of three doses of inhaled nitric oxide in acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2801%2900270-7

7 January 2021

10.1016/S0952-8180(01)00270-7

Identifiers

DOI

1 reference

25 November 2017

1 reference